Press Releases

Date	Title	Company
31-Mar-2025	Pharmacy Automation Market to Expand at 8.5% CAGR \| Innovations Reshaping the Industry	Medi-Tech Insights
31-Mar-2025	Bioanalytical Services Market Outlook: Set for Double-Digit CAGR Growth by 2027	Medi-Tech Insights
31-Mar-2025	Global Home Healthcare Services Market Set to Grow at ~8–10% CAGR by 2029	Medi-Tech Insights
31-Mar-2025	RYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) demonstrates significant overall survival benefit in patients with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitution mutations versus osimertinib	Johnson & Johnson
31-Mar-2025	Following a planned interim analysis in the PROCEED trial Lundbeck expands the dose finding to intravenous administration of Lu AG09222 in migraine prevention	Lundbeck
31-Mar-2025	MAJOR BREAKTHROUGH IN RESPIRATORY DIAGNOSTICS SET TO TRANSFORM NHS LUNG CARE	TidalSense
31-Mar-2025	Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors	Sanofi
31-Mar-2025	VIVA Pediatric Healthcare Expands With Acquisition of Two PPECCs in Longview and Lubbock, Texas	ACCESS NewsWire
31-Mar-2025	Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms	Abbott
31-Mar-2025	Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine	Moderna
31-Mar-2025	Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025	Novo Nordisk
31-Mar-2025	Lilly's lepodisiran reduced levels of genetically inherited heart disease risk factor, lipoprotein(a), by nearly 94% from baseline at the highest tested dose in adults with elevated levels	Lilly
31-Mar-2025	Calquence plus chemoimmunotherapy recommended for approval in the EU by CHMP as first and only BTK inhibitor for 1st-line mantle cell lymphoma	AstraZeneca
31-Mar-2025	Imfinzi approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer	AstraZeneca
31-Mar-2025	NLS Pharmaceutics and Kadimastem Announces Up to $3 Million Equity Financing and $25 Million Equity Facility Agreement	ACCESS NewsWire
31-Mar-2025	Rancho BioSciences Appoints Marc Ginsky as Chief Executive Officer	ACCESS NewsWire
31-Mar-2025	The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium	ACCESS NewsWire
31-Mar-2025	ZetrOZ Systems to Showcase sam(R) Wearable Ultrasound Unit for Pro Football Trainers	ACCESS NewsWire
31-Mar-2025	ONI's LNP Profiler Kit With AutoLNP: Revolutionizing Lipid Nanoparticle Characterization With Super-Resolution Microscopy	ACCESS NewsWire
31-Mar-2025	International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results	ACCESS NewsWire